Your browser doesn't support javascript.
loading
Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring.
Oda, Kazutaka; Yamaguchi, Ayami; Matsumoto, Naoya; Nakata, Hirotomo; Higuchi, Yusuke; Nosaka, Kisato; Jono, Hirofumi; Saito, Hideyuki.
Afiliação
  • Oda K; Departments of Pharmacy and.
  • Yamaguchi A; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
  • Matsumoto N; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.
  • Nakata H; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.
  • Higuchi Y; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
  • Nosaka K; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
  • Jono H; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
  • Saito H; Departments of Pharmacy and.
Ther Drug Monit ; 46(1): 80-88, 2024 02 01.
Article em En | MEDLINE | ID: mdl-37735762
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neutropenia Febril / Linfoma / Mieloma Múltiplo Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neutropenia Febril / Linfoma / Mieloma Múltiplo Idioma: En Ano de publicação: 2024 Tipo de documento: Article